Position in JAZZ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$412,924,262
+$54,633,868 QoQ
Shares Held
1,713,592
-9.6% QoQ
Ownership
2.64%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 5%
None 3%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,748,551 across 230 Biotechnology names. JAZZ ranks #2 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in JAZZ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $412,924,262 | 1,713,592 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $358,290,394 | 1,895,215 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $445,961,510 | 2,623,303 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $373,870,732 | 2,836,652 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $269,315,259 | 2,537,837 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $289,074,583 | 2,328,430 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $250,618,869 | 2,035,070 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $190,995,285 | 1,714,346 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $130,445,189 | 1,222,198 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $99,183,810 | 823,649 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $94,199,058 | 765,846 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $102,984,016 | 795,612 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $101,893,793 | 821,923 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $122,917,636 | 840,003 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $133,431,998 | 837,562 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $126,997,376 | 952,790 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $156,695,038 | 1,004,391 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $157,132,986 | 1,009,398 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $126,910,911 | 996,161 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $122,803,134 | 943,116 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $158,842,135 | 894,180 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $147,697,622 | 898,568 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $146,018,084 | 884,690 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $126,765,219 | 889,019 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $101,979,979 | 924,234 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $95,940,105 | 961,902 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||